Background: HIV-1 infection elicits host gene expression changes that may impact clinical outcomes. Non-human primate studies suggest that early and persistent expression of interferon-stimulated genes differentiate poor outcomes of SIV infection in rhesus macaques from less severe outcomes in sooty mangabeys. We assessed host gene expression in African HIV-1 seroconverters before HIV-1 acquisition through chronic infection to determine if early changes in gene expression associate with subsequent HIV-1 plasma RNA levels and CD4/CD8 ratios.
Methods: Genome-wide gene expression microarrays were performed on 78 whole blood samples from 17 African HIV-1 seroconverters, including 14 pre and 64 post-infection samples (up to 450 days post-infection) collected from HIV-1 serodiscordant heterosexual couples. For each gene, we evaluated expression changes relative to pre-infection levels using cubic spline linear models to flexibly fit the relationship between expression and time. We used linear regression to determine associations between gene expression changes <90 days after infection with HIV-1 RNA set point and CD4/CD8 ratios >1 year after infection. Ingenuity pathway analysis identified gene sets. P-values were adjusted for multiple testing by controlling the false discovery rate (FDR).
Results: Expression of 1808 genes changed after HIV-1 infection (FDR<5%). Of these, the maximum expected fold-change during follow-up was 1.4-2 for 408 genes, and >2 for 35 genes. Within 90 days after HIV-1 infection, expression of 7 genes involved in T-cell receptor signaling (e.g. CD8a and CD8b) increased nearly 2-fold versus pre-infection levels before subsequently declining (p=0.03)(Figure 1a). Expression of 28 genes involved in the Type I interferon (IFN) pathway (e.g., IFI27, IFI44, MX1, Tetherin, OAS1/2) increased rapidly <90 days after infection and remained elevated throughout follow-up (p=9.7×10-10,FDR<5%)(Figure 1b). IFI27 expression increased most with a 4-fold increase by 90 days after infection (p=0.0007,FDR=2%). Increased expression of genes in the Type I IFN pathway <90 days after infection was associated with increased CD4/CD8 ratios (p=2×10-7,FDR<5%), but not HIV-1 set point.
Conclusions: Similar to rhesus macaques, Type I IFN stimulated genes are persistently expressed during early HIV-1 infection. Expression of these genes is associated with CD4/CD8 ratio but not HIV-1 set point. Further research is needed to identify mechanisms for how ISG expression may alter clinical outcomes.
Temporal trajectories of representative genes involved in T-cell receptor signaling (A) and Type I inferferon responses (B). Trajectories were determined using cubic spline linear models to allow flexible relationships between time since HIV-1 infection and gene expression changes. Post-infection gene expression values were evaluated relative to pre-infection values to allow analysis of within-person changes in gene expression.